Pivotal bioVenture Partners Investment Advisor as of June 30, 2026
Portfolio Holdings for Pivotal bioVenture Partners Investment Advisor
Pivotal bioVenture Partners Investment Advisor holds 13 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vaxcyte (PCVX) | 26.9 | $83M | 1.4M | 58.13 | |
| Arcutis Biotherapeutics (ARQT) | 10.8 | $33M | 1.3M | 26.22 | |
| Trevi Therapeutics (TRVI) | 10.6 | $33M | 1.7M | 18.65 | |
| Avalyn Pharmaceuticals Com Shs | 10.3 | $32M | 967k | 32.92 | |
| Evommune Com Shs (EVMN) | 8.3 | $26M | 1.9M | 13.29 | |
| Maplight Therapeutics (MPLT) | 7.1 | $22M | 611k | 35.84 | |
| Oculis Holding Ordinary Shares (OCS) | 6.8 | $21M | 1.5M | 13.87 | |
| Bioage Labs (BIOA) | 5.2 | $16M | 653k | 24.51 | |
| Immunome (IMNM) | 5.0 | $16M | 733k | 21.19 | |
| Zenas Biopharma (ZBIO) | 4.0 | $13M | 491k | 25.38 | |
| Avalo Therapeutics Com New (AVTX) | 2.6 | $8.0M | 434k | 18.48 | |
| Rallybio Corp (RLYB) | 1.6 | $4.8M | 301k | 16.00 | |
| Recursion Pharmaceuticals In Cl A (RXRX) | 0.7 | $2.2M | 596k | 3.67 |
